Abstract

Intra-clot, pulse-sprayed tissue plasminogen activator has lysed 12 of 18 deep venous thrombi related to venous access devices. The treatment appears to be quite safe. However, venous potency has persisted only in veins from which the inciting catheters have been removed. (Protocol 95-CC-053)

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010250-02
Application #
2571438
Study Section
Cognition and Perception Study Section (CP)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code